3WJ – targeting ligand
Purpose:This nanoparticle can be used for specific targeting of desired cell populations.
Get Quote| Product Name | Catalog number | Synthesis scale | |
|---|---|---|---|
|
Triple Negative Breast Cancer (TNBC)
|
3WJ – RFA (TNBC)-FL | RNP-F01-1 |
1 nmol
|
| RNP-F01-2 |
50 nmol
|
||
|
[Description: Near Infrared labeled serum stable 3WJ RNA nanoparticle with an aptamer targeting Triple Negative Breast Cancer (TNBC) cells] |
|||
| 3WJ – RFM-FL | RNP-F07-1 | 1 nmol | |
| RNP-F07-2 | 50 nmol | ||
|
[Description: Near Infrared labeled serum stable 3WJ RNA nanoparticle with a mutant aptamer (serving as a targeting control)] |
|||
|
HER2 +
Cancer
|
3WJ – RFA (HER2)-FL | RNP-F03-1 | 1 nmol |
| RNP-F03-2 | 50 nmol | ||
|
[Description: Near Infrared labeled serum stable 3WJ RNA nanoparticle with an aptamer targeting HER2 + cancer cells] |
|||
| 3WJ – RFM-FL | RNP-F07-1 | 1 nmol | |
| RNP-F07-2 | 50 nmol | ||
|
[Description: Near Infrared labeled serum stable 3WJ RNA nanoparticle with a mutant aptamer (serving as a targeting control)] |
|||
|
Folate Receptor+ Cancer
|
3WJ – RFC (FA)-FL | RNP-F05-1 | 1 nmol |
| RNP-F05-2 | 50 nmol | ||
|
[Description: Near Infrared labeled serum stable 3WJ RNA nanoparticle with a folate ligand for targeting folate receptor (+) cells] |
|||
| 3WJ – RF-FL | RNP-F08-1 | 1 nmol | |
| RNP-F08-2 | 50 nmol | ||
|
[Description: Near Infrared labeled serum stable 3WJ RNA nanoparticle without ligand (serving as vector control)] |
|||
|
Epithelial Cancer (EC)
|
3WJ – RFA (EC)-FL | RNP-F04-1 | 1 nmol |
| RNP-F04-2 | 50 nmol | ||
|
[Description: Near Infrared labeled serum stable 3WJ RNA nanoparticle with an aptamer targeting Epithelial Cancer (EC) cells] |
|||
| 3WJ – RFM-FL | RNP-F07-1 | 1 nmol | |
| RNP-F07-2 | 50 nmol | ||
|
[Description: Near Infrared labeled serum stable 3WJ RNA nanoparticle with a mutant aptamer (serving as a targeting control)] |
|||
|
Galactose receptor +
Cancer
|
3WJ – RFC (GL)-FL | RNP-F06-1 | 1 nmol |
| RNP-F06-2 | 50 nmol | ||
|
[Description: Near Infrared labeled serum stable 3WJ RNA nanoparticle with a galactose ligand for targeting liver cancer cells] |
|||
| 3WJ – RF-FL | RNP-F07-1 | 1 nmol | |
| RNP-F07-2 | 50 nmol | ||
|
[Description: Near Infrared labeled serum stable 3WJ RNA nanoparticle without ligand (serving as vector control)] |
|||
|
PSMA+
Cancer
|
3WJ – RFA (PC)-FL | RNP-F02-1 | 1 nmol |
| RNP-F02-2 | 50 nmol | ||
|
[Description: Near Infrared labeled serum stable 3WJ RNA nanoparticle with an aptamer targeting Prostate Cancer (PC) cells] |
|||
| 3WJ – RFM-FL | RNP-F03-1 | 1 nmol | |
| RNP-F04-2 | 50 nmol | ||
|
[Description: Near Infrared labeled serum stable 3WJ RNA nanoparticle with a mutant aptamer (serving as a targeting control)] |
|||
